Delivery Order SPE2DB24D2010-SPE2DB25FAAUH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,138.04 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,002.64 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Briviact 100 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Briviact 100 mg tablets (60-count packaging). This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,706.39 and an ultimate completion date of August 15, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Briviact 75 mg tablets (60-count units) with a ceiling value of $3,651.35. This firm fixed-price delivery order, which is expected to be completed by August 5, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,443.28 on July 28, 2025, for the supply of Briviact 100 mg tablets in a 60-count package. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's capability to compete in the...
- The Defense Logistics Agency awarded a delivery order valued at $19,116.30 to AmerisourceBergen Drug Corp for the supply of Briviact 10 mg/mL oral solution in 300 mL quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 6, 2025, and was awarded on August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $5,833.23 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $1,905.41 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 25 mg on July 21, 2025, with a completion date of July 22, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,569.98 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Briviact 50 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by July 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAUHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems. The company's DLA prime contract vehicle enables comprehensive global pharmaceutical support, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Briviact, an antiepileptic medication, reflects the company's ongoing role in supplying specialized pharmaceutical products through the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/12/25 |